173
Participants
Start Date
June 27, 2011
Primary Completion Date
June 11, 2013
Study Completion Date
June 11, 2013
VP20621
VP20621 as oral liquid once daily for 7 days followed by placebo as oral liquid once daily for seven days
VP20621
VP20621 as oral liquid once daily for 7 days followed by placebo as oral liquid once daily for 7 days
Placebo
10 mL placebo once daily for 14 days
VP20621
VP20621 as oral liquid once daily for 14 days
Modesto
Palm Desert
Sacramento
Aurora
Hartford
Bay Pines
Jacksonville
Honolulu
Chicago
Maywood
Anderson
Lafayette
Lexington
New Orleans
Chevy Chase
Detroit
Grosse Pointe Woods
Novi
Royal Oak
Sault Ste. Marie
Rochester
St Louis
Butte
Omaha
Albany
New York
North Massapequa
Syracuse
The Bronx
Winston-Salem
Akron
Cleveland
Lima
Toledo
Lancaster
West Reading
Memphis
Houston
Temple
Salt Lake City
Winchester
Tacoma
Aalst
Brussels
Leuven
Liège
Calgary
Hamilton
Chicoutimi
Montreal
Trois-Rivières
Cologne
Hanover
Leipzig
Wilhelmshaven
Seville
Barcelona
Majadahonda
Lugano
Lead Sponsor
Shire
INDUSTRY